Published online Nov 26, 2020. doi: 10.12998/wjcc.v8.i22.5744
Peer-review started: August 6, 2020
First decision: August 22, 2020
Revised: September 12, 2020
Accepted: September 23, 2020
Article in press: September 23, 2020
Published online: November 26, 2020
Processing time: 111 Days and 7.2 Hours
Gastric mixed adenoma-neuroendocrine tumors (NETs) are quite rare. In the 2019 world health organization classification of tumors of the digestive system, these were designated as a combination of grade 1 or grade 2 NETs and adenomas or tubular adenomas. There are no treatment guidelines for these tumors, and pathological and clinical studies are ongoing. Herein, we review previous case reports and present a case of gastric mixed adenoma-NET.
A 66-year-old man underwent gastrointestinal endoscopy for the evaluation of upper abdominal pain. Histopathological examination of the biopsy specimen indicated the possibility of gastric cancer. A histopathological examination by endoscopic submucosal dissection showed a mixed adenoma-NET that was completely excised by endoscopic submucosal dissection. No recurrence was observed on gastrointestinal endoscopy at the 6-mo follow-up.
Clinicians' awareness of this rare tumor is important for its timely diagnosis and treatment.
Core Tip: Neuroendocrine tumors are rare tumors, and analysis and classification of tumors have progressed due to recent advances in immunostaining and gene analysis. The mixture of gastric adenoma or adenocarcinoma with neuroendocrine tumor is quite rare, and it is interesting to investigate the mechanism of tumor development and differentiation. We experienced a case of mixed adenoma- neuroendocrine tumors and considered problems in diagnosis and treatment, so we will report it together with other reported cases.